BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1493439)

  • 1. The association of c-myc rearrangements with specific types of human non-Hodgkin's lymphomas.
    Van Krieken JH; Kluin PM
    Leuk Lymphoma; 1992 Aug; 7(5-6):371-6. PubMed ID: 1493439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of the lymphomas: cytogenetics, molecular biology, and virology.
    Ambinder RF; Griffin CA
    Curr Opin Oncol; 1991 Oct; 3(5):806-12. PubMed ID: 1661167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and Burkitt's lymphoma.
    Magrath I; Jain V; Bhatia K
    Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt's lymphomas.
    Syrjänen S; Kallio P; Sainio P; Fuju C; Syrjänen K
    Scand J Dent Res; 1992 Jun; 100(3):176-80. PubMed ID: 1321486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
    Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
    J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
    Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
    Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of Burkitt's lymphoma.
    Hecht JL; Aster JC
    J Clin Oncol; 2000 Nov; 18(21):3707-21. PubMed ID: 11054444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
    Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of AIDS-associated non-Hodgkin's lymphoma.
    Shiramizu B; McGrath MS
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):323-30. PubMed ID: 2022596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association.
    Shiramizu B; Barriga F; Neequaye J; Jafri A; Dalla-Favera R; Neri A; Guttierez M; Levine P; Magrath I
    Blood; 1991 Apr; 77(7):1516-26. PubMed ID: 1849033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
    Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
    N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is Burkitt's lymphoma?
    Wright DH
    J Pathol; 1997 Jun; 182(2):125-7. PubMed ID: 9274520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's new in lymphoma cytogenetics?
    Kristoffersson U
    Pathol Res Pract; 1988 Feb; 183(1):100-6. PubMed ID: 3362747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
    Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Bauml G; Rucker O; Schwarzmann F; Wolf H; Minarovits J
    Med Sci Monit; 2003 Jan; 9(1):HY1-9. PubMed ID: 12552250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation.
    De Falco G; Ambrosio MR; Fuligni F; Onnis A; Bellan C; Rocca BJ; Navari M; Etebari M; Mundo L; Gazaneo S; Facchetti F; Pileri SA; Leoncini L; Piccaluga PP
    BMC Cancer; 2015 Oct; 15():668. PubMed ID: 26453442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rearrangements of c-myc and c-abl genes in tumour cells in Burkitt's lymphoma.
    Casares S; Rodríguez JM; Martin A; Parrado A
    J Clin Pathol; 1993 Aug; 46(8):778-9. PubMed ID: 8408711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epstein-Barr virus and Burkitt's lymphoma].
    Joab I
    Med Trop (Mars); 1999; 59(4 Pt 2):499-502. PubMed ID: 10901854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas.
    Clark HM; Yano T; Otsuki T; Jaffe ES; Shibata D; Raffeld M
    Cancer Res; 1994 Jul; 54(13):3383-6. PubMed ID: 8012955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
    Müller JR; Janz S; Potter M
    Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.